<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cardiac magnetic resonance imaging (CMR) can play a key role in the assessment and follow-up of patients with stage B <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>CMR currently serves as the reference standard for quantifying right and left ventricular size and ejection fraction </plain></SENT>
<SENT sid="2" pm="."><plain>Technical advances have also enabled CMR to provide noninvasive tissue characterization and detailed assessments of myocardial performance </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, in addition to standard metrics of cardiac structure and function, CMR offers a variety of tools for determining cause, severity, and estimating the prognosis associated with an asymptomatic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
</text></document>